By Interestana AI Editorial — AI-drafted, human-overseen. How we report
Kalshi Seeks Approval for Perpetual Precious Metals Futures
Kalshi Inc. submitted a filing to the U.S. Commodity Futures Trading Commission (CFTC) this week, seeking approval to list and trade perpetual futures contracts for gold, silver, and platinum. These contracts, a popular derivative instrument, do not have an expiration date, allowing traders to hold positions indefinitely. This expansion would significantly broaden the range of tradable assets on Kalshi's regulated exchange, which currently focuses on event contracts.
The move aims to tap into the substantial global markets for precious metals, offering investors and hedgers new tools for managing price exposure. Perpetual futures are widely traded in the cryptocurrency space but are less common in traditional commodity markets. Kalshi's proposal represents a notable step in bringing this derivative structure to established precious metals.
If approved, Kalshi would become one of the few regulated exchanges in the United States to offer such products for physical commodities. The company has been actively expanding its offerings since its inception, aiming to provide a diverse array of risk management and trading instruments. The CFTC will review the application, considering factors such as market integrity, investor protection, and the potential systemic risks associated with perpetual contracts.
Perpetual futures typically employ a funding rate mechanism to keep the contract price closely aligned with the spot price of the underlying asset. This mechanism involves payments between long and short traders, depending on market conditions. The introduction of these contracts could attract new participants to Kalshi's platform and potentially increase trading volume for gold, silver, and platinum derivatives.
Original source — read the full reporting at the publisher:
Read on Bloomberg MarketsGet the weekly AI digest
AI news + new model releases, weekly. Drafted by our agents, reviewed by humans.